et.al. The frequency of anti-infliximab antibodies in patients with rheumatoid
arthritis treated in routine care and the associations with adverse drug
reactions and treatment failure. Rheumatology Jul 2013; 52(7): 1245-53.
Sanderson JD, Irving PM. Anti-infliximab antibodies in inflammatory bowel
disease: prevalence, infusion reactions, immunosuppression and response, a
meta-analysis. Eur J Gastroenterol Hepatol Sep 2012; 24(9): 1078-85.
GR. Letter from the Editor. Gastro Hepato Feb 2012.
et.al. Infliximab for induction and maintenance therapy for ulcerative colitis.
NEJM 2005; 353:2462-76
et.al. Cut-off levels and diagnostic accuracy of infliximab trough levels and
anti-infliximab antibodies in Crohn’s disease. Scan J Gastroenterol Mar 2011;
Use of combined measurements of serum infliximab and anti-infliximab antibodies
in the treatment of patients with Crohns disease failing infliximab therapy;
ongoing study; accessed at
on 7 August 2013.